Drug Trial Radar · NCT06722664
Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.
Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
336
Planned (sponsor's estimate)
Start
Dec 19, 2024
Primary completion
May 15, 2025
Study completion May 15, 2025
Sponsor
- Lead sponsor
- Healthgen Biotechnology Corp.Industry
- Sponsor type
- Industry
- Collaborators
- Beijing Friendship Hospital
- First posted
- Dec 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study was designed to evaluate efficacy of OsrhCT and Dimethicone emulsion before upper endoscopy on visibility of gastric mucosa. A total of 336 subjects (both male and female) are expected to be enrolled in this trial.
Conditions
- Gastric Mucosal Lesion
Interventions
Recombinant Human Chymotrypsin(OsrhCT) 4000UDrug
Recombinant Human Chymotrypsin (OsrhCT), provided by Wuhan Healthgen Biotechnology Corporation, 4,000U/vial, freeze-dried powder
Placebo for Recombinant Human Chymotrypsin(OsrhCT)Drug
Recombinant Human Chymotrypsin (OsrhCT), provided by Wuhan Healthgen Biotechnology Corporation, 0 U/vial, freeze-dried powder
Dimethicone emulsion 4mlDrug
Dimethicone emulsion,produced by Sichuan Jian Neng Pharmaceutical Co., Ltd, 6ml/bottle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total visibility score (TVS) evaluated by blinded endoscopistsTime frame: Through study completion, an average of 3 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
Chinese PLA Central Theatre General Hospital
Wuhan, Hubei, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
the Central Hospital of Wuhan
Wuhan, Hubei, China
Inner Mongolia Autonomous Region People's Hospital
Hohhot, Inner Mongolia, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.